A quality-by-design approach that defines potential viral contaminants of source materials can be used to achieve viral clearance.
John Zehmer
Advertisement
John Zehmer, PhD, is a scientist and study director, with BioReliance by SAFC, Rockville, MD.
Articles by John Zehmer
Advertisement
Latest Updated Articles
Application of Quality by Design to Viral SafetyPublished: October 1st 2014 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
2
Biotech Equipment Market to Approach $144B by 2030: Implications for Pharma R&D
3
CGT Innovations: The Three-Pronged Strategy for Industry Growth (Part 2)
4
Strategies for Building Tech Talent in the Biopharma Industry (Part 4)
5
